XML 31 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATING INFORMATION (unaudited) (Details 2) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Revenues:          
Rental income $ 325,185 $ 293,671 $ 649,852 $ 560,873  
Resident fees and services 341,594 303,437 680,764 588,630  
Medical office building and other services revenues 3,537 6,639 7,185 12,247  
Income from loans and investments 14,733 8,152 30,836 16,188  
Equity earnings in affiliates      0 0  
Interest and other income 797 65 1,835 112  
Total revenues 685,846 611,964 1,370,472 1,178,050  
Expenses:          
Interest 83,046 72,767 162,452 140,678  
Depreciation and amortization 172,706 187,367 351,495 347,563  
Property-level operating expenses 269,738 236,652 537,187 452,489  
Medical office building services costs 1,667 3,839 3,306 6,827  
General, administrative and professional fees 27,327 26,423 56,101 48,621  
(Gain) loss on extinguishment of debt, net (720) 9,989 (720) 39,533  
Merger-related expenses and deal costs 6,667 36,668 10,929 44,649  
Other 4,385 1,510 8,972 3,086  
Total expenses 564,816 575,215 1,129,722 1,083,446  
Income before income/loss from unconsolidated entities, income taxes, discontinued operations and noncontrolling interest 121,030 36,749 240,750 94,604  
(Loss) income from unconsolidated entities (506) 514 423 831  
Income tax benefit (expense) 12,064 5,179 10,320 (6,159)  
Income from continuing operations 132,588 42,442 251,493 89,276  
Discontinued operations (18,055) 31,294 (23,862) 74,552  
Net income 114,533 73,736 227,631 163,828 361,775
Net (loss) income attributable to noncontrolling interest (47) (289) 858 (823)  
Comprehensive (loss) income attributable to noncontrolling interest (47) (289) 858 (823)  
Net income attributable to common stockholders 114,580 74,025 226,773 164,651  
Ventas, Inc.
         
Revenues:          
Rental income 619 634 1,259 1,258  
Resident fees and services     0 0  
Medical office building and other services revenues     0 0  
Income from loans and investments 1,159 951 1,262 1,890  
Equity earnings in affiliates 105,135 51,602 221,203 112,778  
Interest and other income 259 56 297 85  
Total revenues 107,172 53,243 224,021 116,011  
Expenses:          
Interest (474) (1,513) (941) (2,236)  
Depreciation and amortization 1,213 810 2,292 1,518  
Property-level operating expenses     0 0  
Medical office building services costs     0 0  
General, administrative and professional fees 1,155 2,907 1,143 3,810  
(Gain) loss on extinguishment of debt, net     0 0  
Merger-related expenses and deal costs 4,227 28,689 6,976 30,053  
Other 254 (36) 293 1  
Total expenses 6,375 30,857 9,763 33,146  
Income before income/loss from unconsolidated entities, income taxes, discontinued operations and noncontrolling interest 100,797 22,386 214,258 82,865  
(Loss) income from unconsolidated entities     0 0  
Income tax benefit (expense) 12,064 5,179 10,320 (6,159)  
Income from continuing operations 112,861 27,565 224,578 76,706  
Discontinued operations 1,719 46,460 2,195 87,945  
Net income 114,580 74,025 226,773 164,651  
Comprehensive (loss) income attributable to noncontrolling interest     0 0  
Net income attributable to common stockholders 114,580 74,025 226,773 164,651  
Ventas Issuers
         
Revenues:          
Rental income 70,342 68,939 140,075 136,374  
Resident fees and services     0 0  
Medical office building and other services revenues     0 0  
Income from loans and investments 493 560 787 1,029  
Equity earnings in affiliates     0    
Interest and other income 5 5 11 10  
Total revenues 70,840 69,504 140,873 137,413  
Expenses:          
Interest 35,958 23,820 68,485 44,939  
Depreciation and amortization 7,734 13,138 15,167 20,769  
Property-level operating expenses 140 118 242 241  
Medical office building services costs     0 0  
General, administrative and professional fees 5,165 7,114 10,786 14,112  
(Gain) loss on extinguishment of debt, net   9,989 0 39,720  
Merger-related expenses and deal costs     0 0  
Other     21 0  
Total expenses 48,997 54,179 94,701 119,781  
Income before income/loss from unconsolidated entities, income taxes, discontinued operations and noncontrolling interest 21,843 15,325 46,172 17,632  
(Loss) income from unconsolidated entities 217 514 505 831  
Income tax benefit (expense)     0 0  
Income from continuing operations 22,060 15,839 46,677 18,463  
Discontinued operations 209 1,315 604 3,426  
Net income 22,269 17,154 47,281 21,889  
Comprehensive (loss) income attributable to noncontrolling interest     0 0  
Net income attributable to common stockholders 22,269 17,154 47,281 21,889  
Ventas Subsidiaries
         
Revenues:          
Rental income 254,224 224,098 508,518 423,241  
Resident fees and services 341,594 303,437 680,764 588,630  
Medical office building and other services revenues 3,537 6,639 7,185 12,247  
Income from loans and investments 13,081 6,641 28,787 13,269  
Equity earnings in affiliates 223 172 473 219  
Interest and other income 533 4 1,527 17  
Total revenues 613,192 540,991 1,227,254 1,037,623  
Expenses:          
Interest 47,562 50,460 94,908 97,975  
Depreciation and amortization 163,759 173,419 334,036 325,276  
Property-level operating expenses 269,598 236,534 536,945 452,248  
Medical office building services costs 1,667 3,839 3,306 6,827  
General, administrative and professional fees 21,007 16,402 44,172 30,699  
(Gain) loss on extinguishment of debt, net (720)   (720) (187)  
Merger-related expenses and deal costs 2,440 7,979 3,953 14,596  
Other 4,131 1,546 8,658 3,085  
Total expenses 509,444 490,179 1,025,258 930,519  
Income before income/loss from unconsolidated entities, income taxes, discontinued operations and noncontrolling interest 103,748 50,812 201,996 107,104  
(Loss) income from unconsolidated entities (723)   (82) 0  
Income tax benefit (expense)     0 0  
Income from continuing operations 103,025 50,812 201,914 107,104  
Discontinued operations (19,983) (16,481) (26,661) (16,819)  
Net income 83,042 34,331 175,253 90,285  
Net (loss) income attributable to noncontrolling interest 47 289      
Comprehensive (loss) income attributable to noncontrolling interest     858 (823)  
Net income attributable to common stockholders 83,089 34,620 174,395 91,108  
Consolidated Eliminations
         
Revenues:          
Rental income     0 0  
Resident fees and services     0 0  
Medical office building and other services revenues     0 0  
Income from loans and investments     0 0  
Equity earnings in affiliates (105,358) (51,774) (221,676) (112,997)  
Interest and other income     0 0  
Total revenues (105,358) (51,774) (221,676) (112,997)  
Expenses:          
Interest     0 0  
Depreciation and amortization     0 0  
Property-level operating expenses     0 0  
Medical office building services costs     0 0  
General, administrative and professional fees     0 0  
(Gain) loss on extinguishment of debt, net     0 0  
Merger-related expenses and deal costs     0 0  
Other     0 0  
Total expenses     0 0  
Income before income/loss from unconsolidated entities, income taxes, discontinued operations and noncontrolling interest (105,358) (51,774) (221,676) (112,997)  
(Loss) income from unconsolidated entities     0 0  
Income tax benefit (expense)     0 0  
Income from continuing operations (105,358) (51,774) (221,676) (112,997)  
Discontinued operations     0 0  
Net income (105,358) (51,774) (221,676) (112,997)  
Comprehensive (loss) income attributable to noncontrolling interest     0 0  
Net income attributable to common stockholders (105,358) (51,774) (221,676) (112,997)  
All Other
         
Revenues:          
Rental income     0 0  
Resident fees and services     0 0  
Medical office building and other services revenues 263   263 0  
Income from loans and investments 14,733 8,152 30,836 16,188  
Interest and other income 797 65 1,835 112  
Total revenues 15,793 8,217 32,934 16,300  
Expenses:          
Property-level operating expenses     0 0  
Medical office building services costs     0 0  
(Loss) income from unconsolidated entities $ (191)   $ (191) $ 0